Biotech funding: conversion into tools and CRO orders · Campaigns
Biotech funding: conversion into tools and CRO orders
monitoring · Biotech
Ideas and calls
Long, bearish, hedge and relative-value ideas can coexist. Only explicitly issued calls enter the existing scoreboard; short and hedge performance is not graded.
Issued calls · returns compare the symbol with SPY after 30 and 90 days. Positive excess supports a BUY; negative excess supports TRIM or SELL. WAIT and research ideas have no score. These are call outcomes, not a campaign return.
after the current reset prints a higher low, reclaims the 50-day ($35.56) with RSI above 55 and relative volume at least 1.0x
Invalidation: a settled close below the 200-day ($30.93) before the reclaim breaks this reset
after a pullback to the $210.39 volume shelf, holds and turns back above it with RSI in the 55-65 reset band and relative volume at least 1.0x
Invalidation: a settled close below the 200-day ($202.97) breaks the quality-laggard trend structure
after the current reset prints a higher low, reclaims the 50-day ($35.08) with RSI above 55 and relative volume at least 1.0x
Invalidation: a settled close below the $32.63 support shelf before the reclaim breaks this reset
the pop already happened (Feb low $2.78 to a $8.44 high) — this is the first flag; interest is the 52-week-high reclaim above $8.45, which would say the pullback was digestion, not distribution
Invalidation: a finish under the 50-day (~$5.56) — the four-month turn structure is broken there and it goes back to being a runway story